Scientists have long known that some viruses and bacteria begin infections by latching first onto sugar molecules on the surfaces of cells lining the sinuses and throat of mammals, including humans.

Gene therapy using lentiviral vectors (LVs) has proven effective in ex vivo applications, where a patient’s stem cells are extracted, genetically modified, and then reinfused to achieve therapeutic ...